Exchange Procedure

RNS Number : 8728N
Marwyn Value Investors Limited
27 September 2019
 

LEI: 213800L5751QTTVEA774

 

27 September 2019

 

MARWYN VALUE INVESTORS LIMITED (THE "COMPANY")

 

EXCHANGE PROCEDURE

 

 

The Company announces that it has approved the utilisation of the Exchange Procedure (as defined and described in the Company's prospectus dated 19 October 2016) to exchange 5,131,610 ordinary shares in the capital of the Company ("Ordinary Shares") held by Marwyn Value Investors LP (the "Master Fund") for 5,131,610 exchange shares in the capital of the Company ("Exchange Shares").

4,030,625 of the Ordinary Shares were acquired by the Master Fund under the partial offer made to the Company's ordinary shareholders in January 2019, with shareholder approval to cancel such Ordinary Shares having been received at the Company's AGM on 3 September 2019.

1,100,985 of the Ordinary Shares were acquired by the Master Fund through the Company's share buy back scheme as announced by the Company on 14 September 2018.

Accordingly, the number of Ordinary Shares in issue is reduced from 67,277,490 to 62,145,880. The revised figure should be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interests in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

The number of Exchange Shares in issue now stands at 24,675,946.

 

Company enquiries:

 

Louisa Bonney / Scott Danks

Axio Capital Solutions Limited

Telephone: 01534 761240

 

Gillian Martin / Steve Pearce

Liberum Capital Limited

Telephone: 020 3100 2200

 

PR enquiries:

 

Alex Child-Villiers / Will Barker

Temple Bar Advisory

Telephone: 020 7002 1080


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCPGUCGBUPBGMQ
UK 100

Latest directors dealings